-
AnnouncementsStock TrendInvestor Interaction
-
-
AnnouncementsStock TrendInvestor Interaction
-
APELOA proudly introduces our latest API product, Gabapentin
APELOA has obtained FDA approval for Amantadine Hydrochloride Tablets (100mg)
Grand Opening of the Apeloa Pharma Solutions R&D Center in Billerica, MA
Dr. Yong-Li Zhong as Chief Technology Officer, Chemistry
2024 Interim Report Highlights
APELOA has obtained FDA approval for our Metoprolol Succinate Extended-Release Tablets
Apeloa is among the Top 5 in the China Pharmaceutical CDMO Companies
Dr. Johannes Platzek as Chief Scientific Officer of APELOA CDMO BU
We are proud to announce that Apeloa has received the "API Development & Innovation Award" and the "Premium Global Partner" award at CPHI China 2024!
Hasten Biopharmaceutical Forms Strategic Partnership with Apeloa Pharmaceutical to Enhance Healthcare Innovation
Innovation Milestone: Apeloa Pharmaceutical CDMO Global Service Platform Ready for Use, Pharmaceutical Manufacturing Innovation Forum Held
